What type of syphilis does a 23‑week pregnant woman with a history of reactive rapid plasma reagin six years ago, a low non‑treponemal titer, and a positive treponemal test have?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Classification: Late Latent Syphilis (Previously Treated)

This pregnant patient has late latent syphilis with a history of prior treatment, evidenced by her reactive treponemal antibody (which remains positive for life), low RPR titer of 1:2, and documented reactive RPR six years ago. 1

Staging Rationale

  • Late latent syphilis is defined as infection acquired more than 12 months previously, which clearly applies to this patient with a 6-year history of reactive serology. 1, 2

  • The low RPR titer (1:2) is entirely consistent with late-stage disease, as nontreponemal antibody titers naturally decline over time following infection or treatment, with only 41% of late latent cases maintaining titers >1:8. 2

  • Treponemal antibodies (positive in this patient) remain reactive for life in 75-85% of patients regardless of treatment status, so this result alone cannot distinguish active from previously treated infection. 3

Critical Determination: Adequately Treated vs. Untreated

The single most important clinical question is whether she received appropriate penicillin treatment after that reactive RPR 6 years ago:

If She Was Adequately Treated 6 Years Ago:

  • No additional treatment is required if she received benzathine penicillin G (either 2.4 million units IM × 1 dose for early syphilis OR 2.4 million units IM weekly × 3 weeks for late latent) more than 4 weeks before this pregnancy, her RPR titer declined appropriately (≥4-fold), and there is no evidence of reinfection. 1, 4

  • The current RPR of 1:2 represents a "serofast" state—persistent low-level reactivity that does not indicate treatment failure or active disease. 3, 2

  • Reinfection should be suspected only if there is a 4-fold rise in titer above her established baseline (e.g., if her post-treatment titer was 1:1 and is now 1:4, or if it was nonreactive and is now 1:2). 3

If Treatment History Is Unknown or Inadequate:

  • She must be treated immediately as late latent syphilis with benzathine penicillin G 2.4 million units IM once weekly for 3 consecutive weeks (total 7.2 million units). 1, 2

  • Penicillin is the only acceptable treatment during pregnancy to prevent congenital syphilis; if she reports penicillin allergy, she must undergo desensitization. 1, 4

  • Treatment must be completed at least 4 weeks before delivery to be considered adequate for preventing congenital infection. 1, 4

Mandatory Concurrent Actions

  • Review all prenatal and historical medical records to document: (1) whether she received penicillin treatment after the positive test 6 years ago, (2) what her RPR titers were at that time and subsequently, and (3) whether titers declined ≥4-fold after treatment. 4

  • HIV testing is essential immediately if not already performed this pregnancy, as HIV coinfection significantly increases neurosyphilis risk and alters monitoring requirements. 4, 3, 2

  • Assess for any neurologic or ocular symptoms (headache, vision changes, cranial nerve dysfunction) that would mandate CSF examination to exclude neurosyphilis. 1, 4

Infant Management

  • If the mother was untreated or inadequately treated (treatment <4 weeks before delivery, wrong antibiotic, or no documented 4-fold titer decline), the infant requires full evaluation including CSF examination, long-bone radiographs, CBC with platelets, and treatment with aqueous crystalline penicillin G 100,000-150,000 units/kg/day IV for 10 days. 1, 4

  • If the mother received adequate treatment >4 weeks before delivery with documented serologic response, the infant may require only a single dose of benzathine penicillin G 50,000 units/kg IM or close serologic follow-up without treatment. 1, 4

Follow-Up Monitoring

  • Quantitative RPR titers should be checked at 6,12, and 24 months after any new treatment using the same test method and laboratory. 3, 2

  • Infant nontreponemal titers should be monitored at 3,6,12, and 15 months of age; passively transferred maternal antibodies should decline and become nonreactive by 6 months. 4

Critical Pitfalls to Avoid

  • Never use the treponemal test result to monitor disease activity or treatment response—it remains positive for life regardless of cure. 4, 3

  • Do not assume low titers mean no treatment is needed—if her treatment history is uncertain, she requires the full 3-week late latent regimen regardless of the 1:2 titer. 2

  • Do not delay treatment waiting for old records—if documentation cannot be obtained promptly, treat empirically as untreated late latent syphilis to protect the fetus. 4

  • Do not use alternative antibiotics (doxycycline, azithromycin, ceftriaxone) during pregnancy—only penicillin prevents congenital syphilis. 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Treatment of Asymptomatic Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Postpartum Patient with Positive VDRL and TPHA

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.